This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2007-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kita-ku, JP (2007)
- Tokyo, JP (2010)
Company Filing History:
Years Active: 2007-2010
Title: Masahiro Nagamuta: Innovator in Imidazolidine Derivatives
Introduction
Masahiro Nagamuta is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of chemistry, particularly in the development of imidazolidine derivatives. With a total of 2 patents to his name, Nagamuta's work has implications in pharmaceuticals and drug development.
Latest Patents
Nagamuta's latest patents focus on imidazolidine derivatives. The first patent provides a compound represented by a specific formula, where A is cyano or similar, B is hydrogen, halogen, or similar, and X and X are independently selected from O and S. The compound is associated with a drug and a pharmaceutical composition containing it. The second patent also details imidazolidine derivatives, where n is an integer from 1 to 20, and R and R can represent a hydrogen atom or a linear or branched C-Calkyl group, along with a drug and a pharmaceutical composition.
Career Highlights
Throughout his career, Nagamuta has worked with notable companies such as Chugai Seiyaku Kabushiki Kaisha and Chugai Seikayu Kabushiki Kaisha. His experience in these organizations has contributed to his expertise in the pharmaceutical industry and innovation in drug development.
Collaborations
Nagamuta has collaborated with several professionals in his field, including Mitsuaki Nakamura and Kazutaka Tachibana. These collaborations have likely enhanced his research and development efforts.
Conclusion
Masahiro Nagamuta is a distinguished inventor whose work on imidazolidine derivatives has the potential to impact the pharmaceutical industry significantly. His contributions and collaborations reflect his commitment to innovation and excellence in his field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
